Armata Pharmaceuticals Funding & Investors
Marina del Rey, CA
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses to improve human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious disease of the microbiome. Armata Pharmaceuticals serves patients in the State of California.
armatapharma.comTotal Amount Raised: $335,241,024
Armata Pharmaceuticals Funding Rounds
Grant
$5,250,000
Grant Investors
MTEC | Medical Technology Enterprise ConsortiumPost Ipo Debt
$35,000,000
Post Ipo Debt Investors
InnovivaPost Ipo Debt
$25,000,000
Post Ipo Debt Investors
InnovivaPost Ipo Debt
$30,000,000
Post Ipo Debt Investors
InnovivaPost Ipo Equity
$45,000,000
Post Ipo Equity Investors
InnovivaPost Ipo Equity
$7,000,000
Post Ipo Equity Investors
InnovivaCystic Fibrosis FoundationPost Ipo Equity
$20,000,000
Series Unknown
$18,999,999
Post Ipo Equity
$13,000,000
Series D
$60,000,000
Series D Investors
Renaissance Holding CompanyPost Ipo Equity
$18,000,000
Post Ipo Equity Investors
Roth Capital PartnersPost Ipo Equity
$12,490,999
Post Ipo Equity Investors
Third SecurityBioscience ManagersRa Capital ManagementPost Ipo Debt
$500,000
Series Unknown
$30,000,000
Series Unknown Investors
Wyssta InvestmentsRenaissance Health ServiceCorvestaSeries Unknown
$15,000,000
IPO
Unknown